AERAS GLOBAL TB VACCINE FOUNDATION
Patent Owner
Stats
- 3 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Dec 17, 2013 most recent publication
Details
- 3 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 44 Total Citation Count
- Sep 07, 2005 Earliest Filing
- 5 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2011/0117,124 ENHANCEMENT OF TRANSGENE EXPRESSION FROM VIRAL-BASED VACCINE VECTORS BY EXPRESSION OF SUPPRESSORS OF THE TYPE I INTERFERON RESPONSEAbandonedAug 29, 08May 19, 11[A61K, C12N, A61P]
2010/0047,286 Recombinant BCG strains with enhanced ability to escape the endosomeAbandonedNov 23, 05Feb 25, 10[A61K, C12N, A61P]
2008/0107,683 Bacterial Packaging Strains Useful for Generation and Production of Recombinant Double-Stranded RNA Nucleocapsids and Uses ThereofAbandonedMay 30, 07May 08, 08[A61K, C12N, A61P]
2006/0115,494 Recombinant BCG strains with attenuated immunosuppressive propertiesAbandonedNov 23, 05Jun 01, 06[A61K, C12N]
2006/0069,052 DNA vaccines that expresses mutant ADP-ribosyItransferase toxins which display reduced, or are devoid of, ADP-ribosyltransferase activityAbandonedSep 07, 05Mar 30, 06[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.